Raymond James Financial Services Advisors, Inc. Ocular Therapeutix, Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 96,644 shares of OCUL stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,644

Previous 72,751 32.84%

Holding current value

$1.14 Million

Previous $497,000 69.01%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$6.45 - $9.23 $154,109 - $220,532	23,893 Added 32.84%	96,644 $840,000
Q2 2024 Jul 19, 2024	BUY	$4.2 - $8.69 $77,981 - $161,347	18,567 Added 34.27%	72,751 $497,000
Q1 2024 Apr 22, 2024	SELL	$3.85 - $10.93 $30,245 - $85,866	-7,856 Reduced 12.66%	54,184 $493,000
Q4 2023 Jan 16, 2024	SELL	$2.08 - $4.52 $25,710 - $55,871	-12,361 Reduced 16.61%	62,040 $276,000
Q3 2023 Oct 24, 2023	BUY	$3.14 - $5.04 $74,220 - $119,130	23,637 Added 46.56%	74,401 $233,000
Q2 2023 Jul 25, 2023	BUY	$4.6 - $7.64 $165,641 - $275,108	36,009 Added 244.05%	50,764 $261,000
Q1 2023 Apr 14, 2023	BUY	$2.79 - $6.27 $4,743 - $10,659	1,700 Added 13.02%	14,755 $77,000
Q4 2022 Feb 08, 2023	SELL	$2.61 - $4.41 $56,944 - $96,217	-21,818 Reduced 62.56%	13,055 $36,000
Q3 2022 Oct 25, 2022	BUY	$4.09 - $6.5 $16,544 - $26,292	4,045 Added 13.12%	34,873 $145,000
Q2 2022 Aug 12, 2022	BUY	$3.01 - $5.22 $27,824 - $48,253	9,244 Added 42.83%	30,828 $124,000
Q1 2022 May 11, 2022	SELL	$4.83 - $7.35 $218,402 - $332,352	-45,218 Reduced 67.69%	21,584 $107,000
Q4 2021 Feb 08, 2022	BUY	$6.16 - $12.07 $265,329 - $519,891	43,073 Added 181.52%	66,802 $466,000
Q3 2021 Nov 02, 2021	SELL	$9.7 - $14.34 $18,080 - $26,729	-1,864 Reduced 7.28%	23,729 $237,000
Q2 2021 Aug 11, 2021	SELL	$13.43 - $19.16 $5,452 - $7,778	-406 Reduced 1.56%	25,593 $363,000
Q1 2021 May 14, 2021	BUY	$15.82 - $22.11 $17,544 - $24,519	1,109 Added 4.46%	25,999 $427,000
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $30,659 - $88,954	3,876 Added 18.44%	24,890 $515,000
Q3 2020 Nov 04, 2020	SELL	$7.36 - $9.87 $210,532 - $282,331	-28,605 Reduced 57.65%	21,014 $160,000
Q2 2020 Jul 17, 2020	BUY	$4.67 - $8.95 $159,447 - $305,579	34,143 Added 220.62%	49,619 $413,000
Q1 2020 Apr 21, 2020	BUY	$3.95 - $7.4 $61,130 - $114,522	15,476 New	15,476 $77,000

Others Institutions Holding OCUL

# of Institutions

204

Shares Held

137M

Call Options Held

743K

Put Options Held

321K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $910M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Ocular Therapeutix, Inc Transaction History